Synthetic Antigen Controls for Immunohistochemistry
August 23rd, 2021
2.8K views
This work documents a simple method to create synthetic antigen controls for immunohistochemistry. The technique is adaptable to a variety of antigens in a wide range of concentrations. The samples provide a reference with which to assess intra- and inter-assay performance and reproducibility.
Overview
This work documents a simple method to create synthetic antigen controls for immunohistochemistry. The technique is adaptable to a variety of antigens in a wide range of concentrations.
Key Study Components
Area of Science
- Immunohistochemistry
- Biological Standards
- Laboratory Techniques
Background
- BSA antigen gels are reproducible IHC standards.
- These standards can supplement existing controls.
- They allow for calibration and standardization of IHC assays.
- Finding a suitable solvent for peptides or proteins is crucial.
Purpose of Study
- To create synthetic antigen controls for IHC.
- To improve intra- and inter-assay performance assessment.
- To provide a reference for reproducibility in assays.
Methods Used
- Preparation of a 25% BSA solution using PBS.
- Mixing antigen and formaldehyde solutions.
- Utilizing standard histology and IHC reagents.
- Creating reproducible standards of known composition.
Main Results
- Development of a reliable method for creating antigen controls.
- Establishment of a protocol that can be adapted for various antigens.
- Demonstration of the importance of solvent selection.
- Provision of tools for labs to standardize IHC assays.
Conclusions
- Synthetic antigen controls enhance assay reliability.
- Standardization is crucial for diagnostic relevance.
- The method is versatile and can be widely applied.
Frequently Asked Questions
What is the significance of synthetic antigen controls?
They provide a reference for assessing assay performance and reproducibility.
How can this method be adapted?
It can be modified for various antigens and concentrations.
What are BSA antigen gels?
They are well-characterized standards used in immunohistochemistry.
Why is solvent selection important?
A suitable solvent is crucial for dissolving peptides or proteins effectively.
What reagents are used in this protocol?
Standard histology and IHC reagents are utilized.
Can different labs use these controls?
Yes, they can help labs calibrate and standardize their IHC assays.
Executive Industry Relevance
Synthetic antigen controls address the challenge of inconsistent immunohistochemistry (IHC) assay performance due to variable biological controls. By providing well-defined, reproducible standards of known antigen concentration, the method enables assay calibration, dynamic range assessment, and inter-laboratory standardization. This supports predictive confidence in target validation and assay optimization for diagnostic and therapeutic antibody development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through controlled antigen titration.
- Operational Value: Provides reproducible positive and negative controls for antibody specificity screening.
- Predictive Value: Supports assessment of antibody sensitivity and dynamic range early in discovery.
Screening & Assay Development
- Scientific Value: Generates quantitative reference standards for assay linearity and limit of detection.
- Operational Value: Standardizes IHC workflows using routine histology reagents and equipment.
- Scalability: Allows creation of multiplexed control arrays for high-throughput antibody screening.
Translational & Preclinical Research
- Translational Continuity: Bridges discovery-stage antibody screening to preclinical validation via consistent IHC readouts.
- Biomarker Alignment: Supports evaluation of antigen expression levels relevant to diagnostic cutoffs.
- Risk Mitigation: Reduces false-negative/false-positive risks in target engagement studies.
Pipeline & Workflow Integration
The method fits within the discovery continuum from early target validation through assay optimization to preclinical reproducibility testing.
- Discovery Biology: Supports hypothesis-driven antibody screening with defined antigen concentrations.
- Screening: Enables standardized, quantitative IHC readouts for antibody comparison.
- Analytics: Produces measurable signal intensity outputs correlating with antigen dilution.
- Translational Research: Connects in vitro antibody performance to tissue-based diagnostic relevance.
- Enterprise Reuse: Establishes a reusable platform for generating antigen controls across multiple projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in antibody specificity and sensitivity.
- Operational Value: Enhances assay reproducibility and reduces variability between laboratories.
- Strategic Value: Improves go/no-go decision efficiency by reducing false leads in antibody selection.
- Portfolio Impact: Enables risk-adjusted prioritization of antibody candidates based on validated performance.
Implementation Considerations
- Requires expertise in peptide/protein handling and histology techniques.
- Depends on access to heat blocks, centrifuges, and tissue processors.
- Necessitates standardization of fixation and embedding protocols across sites.
- Involves optimization of antigen solubility and formaldehyde reaction conditions.
- Limited by the need for antigen purity and sufficient quantity for control generation.
Biopharma FAQs
Why is antigen concentration important in IHC control design?
Defined antigen concentrations allow users to assess assay dynamic range, linearity, and sensitivity. This enables optimization of antibody staining conditions and comparison of performance across laboratories. The method supports quantitative evaluation of immunostaining intensity relative to known input.
How does formaldehyde fixation contribute to control stability?
Formaldehyde cross-links the antigen-BSA mixture, forming a gel that mimics tissue morphology. This allows the synthetic control to be processed, sectioned, and stained like biological tissue. The stabilization ensures durability during histology processing and long-term storage.
What quantitative measurements enable assay comparison?
Signal intensity from stained gel sections can be assessed qualitatively or quantified via digital image analysis. These measurements correlate with antigen concentration across dilution series. Such data supports inter-laboratory standardization and assay performance tracking.
Why are replication requirements critical for control validity?
Replicate gels across dilution series ensure reproducibility and reliability of the control system. Consistent staining patterns across replicates build confidence in assay precision. This supports cross-functional trust in IHC data for decision-making.
What statistical analysis is needed before implementing controls?
Basic comparative analysis of signal intensity across antigen dilutions helps establish assay linearity and detection limits. Variance assessment across replicates supports reproducibility claims. These analyses are essential for validating the control system’s suitability for assay standardization.
Chapters in this video
0:05
Introduction
0:46
Preparation of Stock Solutions and Tools
2:26
Preparation and Dilutions of Peptides
4:18
Preparing BSA-Peptide Gels
5:37
Trimming, Processing, Embedding BSA Gels
7:00
Pilot Evaluation of the Peptide Dilution Series and BSA Gel Tissue Microarray Construction
8:07
Results: Staining of ERBB2/HER2 Peptide TMA with ERBB2/HER2 1+ and 3+ Cell Lines
8:46
Conclusion
